Recognizing the region鈥檚 need to work towards self-sufficiency in plasman products, Bioplasma World Asia 2013 will bring together, for the second consecutive year, the Asian and international blood plasma community on 03-04 September 2013 at the Grand Hyatt, Bali. Plasma fractionators, blood centers, health authorities and other industry stakeholders will converge at this much awaited gathering to discuss strategic issues and explore opportunities within Asia-Pacific鈥檚 plasma therapeutics sector.
Asia faces a shortage in plasma and plasma products, with only 20% of the total world volume being fractionated here, despite comprising 60% of the world鈥檚 population. Several factors come into play, such as insufficient funding and a weak blood collection infrastructure. However, Asian countries have begun to make efforts in strengthening their capacity for plasma fractionation, and developments are underway.
路 Dr. Russell Basser, Senior Vice President of Global Clinical Research & Development, CSL Benring, USA
路 Mr. Jan M. Bult, President and CEO, Plasma Protein Therapeutics Association (PPTA), USA
路 Pan Ruo-Wen, Senior Vice President, Hualan Biologicals, China
路 Dr. Ranjit S. Ajmani, Chief Executive Officer, PlasmaGen BioSciences, Bangalore, India
路 Kim Young-ho, Managing Director, Overseas Business Division, Green Cross Corporation, Korea
路 Dr. Thierry Burnouf, Professor, Taipei Medical University, Taiwan
路 Jan Over, Strategic Affairs, Sanquin Plasma Products, The Netherlands
路 Dr. Wolfgang Teschner, Director of Plasma Product Developmet/Product Support Department, Baxter, Austria
路 Mr. Theo Evers, Senior Advisor, International Plasma Fractionation Association (IPFA), Amsterdam, Netherlands
路 Stephanie Gunn, Deputy General Manager, National Blood Authority, Australia
路 Dr. Yuyun SM Soerdarmono, Director of Central Blood Center, Indonesian Red Cross, Indonesia
路 Dr. Chandra Viswanathan, Senior Vice President, Reliance Life Sciences, India
路 Dr. Chris Shue, President and CEO, Shanghai Syndegen Biopharmaceutical Company, China
路 Dr. Pierre-François Falcou, Alliances Director, LFB Biomedicaments, France
路 Dr. Surinder Singh, Director, National Institute of Biologicals, India
路 Johan Prevot, Executive Director, International Patient Organisation for Primary Immunodeficiencies (IPOPI), Portugal
路 Eric Youssef, European Plasma Market Director, Merck Millipore
路 Jerry A. Holmberg, Director, Scientific Affairs, Novartis Vaccines and Diagnostics, Inc.
Here are some brief testimonials from the attendees of last year鈥檚 event: 鈥淰ery informative and helpful for me to understand the overview of plasma product in Asia!鈥 - Hua Zhang, Chief GMP Inspection, CCE, ShFDA, China. 鈥淕ood start! Looking forward to return!鈥 - K Y Tan, General Manager, Haemonetics, Hong Kong. 鈥淓xcellent content and great information on plasma products!鈥 - Sunil Saigal, Director, Consolidated Products, India.
中文
